Back to search results

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Abroad (travel likely)Recruiting

Conditions

Drug-resistant Tuberculosis · HIV Coinfection · Cost-Benefit Analysis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • South African National Health Laboratory Service, Cape Town, South Africa

    Contact: Study coordinator (Robin M Warren, PhD)
    Contact: Study coordinator (Nabila Ismail, PhD) · nabilai@sun.ac.za
Study leads

  • John Z Metcalfe, MD, PhD

    Principal Investigator

    University of California, San Francisco

View source on ClinicalTrials.gov(opens in a new tab)